Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma.
Diffuse intrinsic pontine gliomas (DIPGs) are highly infiltrative malignant glial neoplasms of the ventral pons that, due to their location within the brain, are unsuitable for surgical resection and consequently have a universally dismal clinical outcome. The median survival time is 9-12 months, wi...
Main Authors: | Taylor, K, Mackay, A, Truffaux, N, Butterfield, Y, Morozova, O, Philippe, C, Castel, D, Grasso, C, Vinci, M, Carvalho, D, Carcaboso, A, de Torres, C, Cruz, O, Mora, J, Entz-Werle, N, Ingram, W, Monje, M, Hargrave, D, Bullock, A, Puget, S, Yip, S, Jones, C, Grill, J |
---|---|
Format: | Conference item |
Published: |
2014
|
Similar Items
-
Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma
by: Taylor, K, et al.
Published: (2014) -
Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma
by: Taylor, K, et al.
Published: (2014) -
ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma
by: Carvalho, D, et al.
Published: (2019) -
ACVR1 mutations in DIPG: lessons learned from FOP.
by: Taylor, K, et al.
Published: (2014) -
Mutant ACVR1 arrests glial cell differentiation to drive tumorigenesis in pediatric gliomas
by: Fortin, J, et al.
Published: (2020)